SELLAS Life Sciences (SLS) EBT Growth (3y) (2014 - 2026)
SELLAS Life Sciences (SLS) EBT Growth (3y) (2014 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 9.34% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 40.43% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 12.01% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -1.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 86.16% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - | -9.77% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.77% |
| Dec 31, 2025 | 4.68% |
| Sep 30, 2025 | -0.17% |
| Jun 30, 2025 | -0.78% |
| Mar 31, 2025 | 28.08% |
| Dec 31, 2024 | 15.71% |
| Sep 30, 2024 | -1.63% |
| Jun 30, 2024 | -19.25% |
| Mar 31, 2024 | -60.77% |
| Dec 31, 2023 | -24.79% |
| Sep 30, 2023 | -27.25% |
| Jun 30, 2023 | -27.96% |
| Mar 31, 2023 | -39.82% |
| Dec 31, 2020 | 20.82% |
| Sep 30, 2020 | 0.49% |
| Jun 30, 2020 | 4.78% |
| Mar 31, 2020 | 9.74% |
| Dec 31, 2017 | 2.06% |
| Sep 30, 2017 | 27.28% |
| Jun 30, 2017 | 38.82% |